Host-pathogen interaction: Enterobacter cloacae exerts different adhesion and invasion capacities against different host cell types.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2023
Historique:
received: 24 02 2023
accepted: 17 07 2023
medline: 26 10 2023
pubmed: 24 10 2023
entrez: 24 10 2023
Statut: epublish

Résumé

New antibiotics are urgently needed due to the huge increase of multidrug-resistant bacteria. The underexplored gram-negative bacterium Enterobacter cloacae is known to cause severe urinary tract and lung infections (UTIs). The pathogenicity of E. cloacae in UTI has only been studied at the bioinformatic level, but until now not within systematic in vitro investigations. The present study assesses different human cell lines for monitoring the early steps of host-pathogen interaction regarding bacterial adhesion to and invasion into different host cells by flow cytometric adhesion assay, classical cell counting assay, gentamicin invasion assay, and confocal laser scanning microscopy. To our knowledge, this is the first report in which E. cloacae has been investigated for its interaction with human bladder, kidney, skin, and lung cell lines under in vitro conditions. Data indicate that E. cloacae exerts strong adhesion to urinary tract (bladder and kidney) and lung cells, a finding which correlates with the clinical relevance of the bacterium for induction of urinary tract and lung infections. Furthermore, E. cloacae ATCC 13047 barely adheres to skin cells (A-431) and shows no relevant interaction with intestinal cells (Caco-2, HT-29), even in the presence of mucin (HT29 MTX). In contrast, invasion assays and confocal laser scanning microscopy demonstrate that E. cloacae internalizes in all tested host cells, but to a different extent. Especially, bladder and kidney cells are being invaded to the highest extent. Defective mutants of fimH and fimA abolished the adhesion of E. cloacae to T24 cells, while csgA deletion had no influence on adhesion. These results indicate that E. cloacae has different pattern for adhesion and invasion depending on the target tissue, which again correlates with the clinical relevance of the pathogen. For detailed investigation of the early host-pathogen interaction T24 bladder cells comprise a suitable assay system for evaluation the bacterial adhesion and invasion.

Identifiants

pubmed: 37874837
doi: 10.1371/journal.pone.0289334
pii: PONE-D-23-05465
pmc: PMC10597508
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0289334

Informations de copyright

Copyright: © 2023 Frutos-Grilo et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Infect Immun. 1992 Jun;60(6):2409-17
pubmed: 1587608
Molecules. 2015 Sep 15;20(9):16770-87
pubmed: 26389872
Front Cell Infect Microbiol. 2020 Sep 29;10:492
pubmed: 33134184
Infect Immun. 2005 Aug;73(8):4834-45
pubmed: 16040997
Clin Microbiol Rev. 2019 Jul 17;32(4):
pubmed: 31315895
Infect Immun. 1994 Nov;62(11):5142-50
pubmed: 7523304
Biochim Biophys Acta. 2001 May 28;1539(1-2):71-84
pubmed: 11389969
J Clin Invest. 1973 Jul;52(7):1673-9
pubmed: 4718959
Future Microbiol. 2020 May;15:649-677
pubmed: 32495702
Appl Microbiol Biotechnol. 2020 Jan;104(1):351-363
pubmed: 31768613
BMC Infect Dis. 2021 Jun 26;21(1):611
pubmed: 34174823
Nucleic Acids Res. 2000 Nov 15;28(22):E97
pubmed: 11071951
J Hosp Infect. 1988 Apr;11(3):197-208
pubmed: 2899104
Front Microbiol. 2019 Sep 03;10:2063
pubmed: 31551993
J Cell Sci. 2020 Mar 13;133(5):
pubmed: 32169835
EMBO J. 2000 Jun 15;19(12):2803-12
pubmed: 10856226
Infect Immun. 1998 Feb;66(2):645-9
pubmed: 9453621
BMC Microbiol. 2008 Apr 18;8:64
pubmed: 18423002
J Infect Dis. 2015 Nov 15;212(10):1646-55
pubmed: 26014801
Braz J Microbiol. 2016 Apr-Jun;47(2):414-6
pubmed: 26991275
J Vis Exp. 2011 May 16;(51):
pubmed: 21633326
Planta Med. 2020 Mar;86(4):247-254
pubmed: 31968378
Eur J Microbiol Immunol (Bp). 2015 Sep 18;5(3):181-7
pubmed: 26495128
Front Microbiol. 2020 Sep 24;11:560488
pubmed: 33072020
BMC Infect Dis. 2011 May 11;11:120
pubmed: 21569334
Mol Microbiol. 1999 Mar;31(6):1747-57
pubmed: 10209747
Antimicrob Agents Chemother. 1979 Dec;16(6):743-9
pubmed: 533256
Infect Immun. 2002 Mar;70(3):1081-6
pubmed: 11854186
Clin Microbiol Rev. 1997 Apr;10(2):220-41
pubmed: 9105752
Urology. 1999 Jul;54(1):56-61
pubmed: 10414727
J Cell Sci. 1993 Nov;106 ( Pt 3):771-83
pubmed: 8308060
Antimicrob Agents Chemother. 2018 Mar 27;62(4):
pubmed: 29339383
Proc Natl Acad Sci U S A. 2000 Jun 6;97(12):6640-5
pubmed: 10829079
Front Microbiol. 2020 Jul 10;11:1609
pubmed: 32754144
Medicina (Kaunas). 2019 Jun 18;55(6):
pubmed: 31216725
J Am Chem Soc. 2019 Jan 16;141(2):936-944
pubmed: 30543411
BMC Microbiol. 2006 Jun 26;6:58
pubmed: 16800879
Infect Immun. 2008 Feb;76(2):562-70
pubmed: 18070906
J Clin Microbiol. 2005 Jul;43(7):3297-303
pubmed: 16000451
Proc Natl Acad Sci U S A. 1995 Mar 14;92(6):2081-5
pubmed: 7892228
Biosci Biotechnol Biochem. 2015;79(2):271-9
pubmed: 25351253
Emerg Infect Dis. 2017 May;23(5):878-880
pubmed: 28418318
Front Cell Infect Microbiol. 2021 Jun 17;11:668766
pubmed: 34222040
Semin Hematol. 2001 Apr;38(2):179-93
pubmed: 11309699
Nat Rev Urol. 2010 Dec;7(12):653-60
pubmed: 21139641
Mol Microbiol. 1998 Oct;30(2):285-93
pubmed: 9791174
PLoS One. 2014 Aug 22;9(8):e105578
pubmed: 25147953
J Ethnopharmacol. 2014 Sep 11;155(2):1125-33
pubmed: 24993887
Phytomedicine. 2022 Sep;104:154302
pubmed: 35809378
Nat Methods. 2012 Jul;9(7):671-5
pubmed: 22930834
Biochem Soc Trans. 2016 Dec 15;44(6):1571-1580
pubmed: 27913666
Front Microbiol. 2020 Apr 07;11:583
pubmed: 32318049
J Ethnopharmacol. 2020 Jul 15;257:112889
pubmed: 32311481
Lung. 2011 Dec;189(6):475-83
pubmed: 22009561
Antimicrob Agents Chemother. 2018 Jan 25;62(2):
pubmed: 29203488

Auteurs

Elisabet Frutos-Grilo (E)

Departament de Genètica i de Microbiologia, Universitat Autònoma de Barcelona, Bellaterra, Spain.

Vanessa Kreling (V)

Institute of Pharmaceutical Biology and Phytochemistry, University of Münster, Münster, Germany.

Andreas Hensel (A)

Institute of Pharmaceutical Biology and Phytochemistry, University of Münster, Münster, Germany.

Susana Campoy (S)

Departament de Genètica i de Microbiologia, Universitat Autònoma de Barcelona, Bellaterra, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH